Status:
COMPLETED
Improving Care of Patients With Heart Failure
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Icahn School of Medicine at Mount Sinai
Conditions:
Depression
Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Heart failure (HF) affects more than 5 million Americans and is a major source of morbidity and mortality. Despite optimal management, over half of patients with HF suffer from pain, dyspnea, fatigue,...
Eligibility Criteria
Inclusion
- HF as primary Dx or symptomatic/active HF
- During index hospitalization or within the prior 6 months
- Age \> 18
- Admit from: hospital, skilled nursing, home
- Medicine, Cardiology, and Heart Failure Services
- Co-morbidities can include end-stage renal disease, metastatic cancer, ICU/CCU care patients if able to consent and complete survey
- English speaking
- Exclusion Criteria:
- Non-English speaking
- Previous consult by Palliative Care Service
- Pulmonary HTN
- Right Heart Failure
- LVAD
- PCI or CABG patient within this admission
- AS with planned surgical intervention
- Pre/post heart transplant
- Pre/post organ transplant within this admission
- Dementia (unable to consent)
- Homeless
- Active drug user
- Hospice enrolled patient
- GeriTraCC patients
- Does not have a UCSF physician
- Lives outside of the SF Bay Area
Exclusion
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01461681
Start Date
March 1 2012
End Date
December 1 2013
Last Update
May 14 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Medical Center
San Francisco, California, United States, 94143
2
University of California San Francisco Medical Center
San Francisco, California, United States, 94143